These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20154344)

  • 1. Onset of peripheral arterial disease: role of endothelin in endothelial dysfunction.
    de Haro Miralles J; Gónzalez AF; Varela Casariego C; García FA
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):760-5. PubMed ID: 20154344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs.
    de Haro Miralles J; Martínez-Aguilar E; Florez A; Varela C; Bleda S; Acin F
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):107-12. PubMed ID: 19376804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
    Tayebjee MH; Tan KT; MacFadyen RJ; Lip GY
    J Intern Med; 2005 Jan; 257(1):110-6. PubMed ID: 15606382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.
    Mangiafico RA; Malatino LS; Spada RS; Santonocito M; Messina R; Dell'Arte S; Attinà T
    Int Angiol; 2000 Mar; 19(1):14-7. PubMed ID: 10853680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C-protein C inhibitor complex in peripheral arterial disease.
    Blomstrand D; Kölbel T; Lindblad B; Gottsäter A
    Ann Vasc Surg; 2010 Jul; 24(5):588-95. PubMed ID: 20409682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise in patients with intermittent claudication elicits signs of inflammation and angiogenesis.
    Palmer-Kazen U; Religa P; Wahlberg E
    Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):689-96. PubMed ID: 19775917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic objective evaluation of peripheral arterial disease by near-infrared spectroscopy.
    Manfredini F; Malagoni AM; Felisatti M; Mandini S; Mascoli F; Manfredini R; Basaglia N; Zamboni P
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):441-8. PubMed ID: 19625198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia.
    Nasser M; Wolosker N; Uint L; Rosoky RA; Lobato M; Wajngarten M; Puech-Leao P
    Thromb Res; 2006; 117(3):271-7. PubMed ID: 15890390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine.
    Kirilov G; Zacharieva S; Alexandrov AS; Lozanov V; Mitev V
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):457-61. PubMed ID: 19907721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome.
    Morillas P; Quiles J; Cordero A; Guindo J; Soria F; Mazón P; Gonzalez-Juanatey JR; Bertomeu V;
    Am J Cardiol; 2009 Dec; 104(11):1494-8. PubMed ID: 19932781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
    Mangiafico RA; Malatino LS; Santonocito M; Sarnataro F; Dell'Arte S; Messina R; Santangelo B
    Panminerva Med; 1999 Mar; 41(1):22-6. PubMed ID: 10230252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
    Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
    Kaperonis EA; Liapis CD; Kakisis JD; Dimitroulis D; Papavassiliou VG; Perrea D; Kostakis AG
    Eur J Vasc Endovasc Surg; 2006 May; 31(5):509-15. PubMed ID: 16427340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.